Commission Implementing Regulation (EU) No 374/2013 of 23 April 2013 concerning the authorisation of a preparation of Clostridium butyricum (FERM BP-2789) as a feed additive for chickens reared for laying (holder of authorisation Miyarisan Pharmaceutical Co. Ltd represented by Miyarisan Pharmaceutical Europe S.L.U.)
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
I Veterinary and Phytosanitary Matters
I.II Feedingstuffs
Joint committee decision (JCD)
002/2014 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) No 374/2013 of 23 April 2013 concerning the authorisation of a preparation of Clostridium butyricum (FERM BP-2789) as a feed additive for chickens reared for laying (holder of authorisation Miyarisan Pharmaceutical Co. Ltd represented by Miyarisan Pharmaceutical Europe S.L.U.)
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) nr. 374/2013 frá 23. apríl 2013 um leyfi fyrir blöndu með Clostridium butyricum (FERM-BP 2789) sem fóðuraukefni fyrir kjúklinga sem eru aldir til að verða varphænur (leyfishafi er Miyarisan Pharmaceutical Co. Ltd, fulltrúi er Miyarisan Pharmaceutical Europe S.L.U.)
Durchführungsverordnung (EU) Nr. 374/2013 der Kommission vom 23. April 2013 zur Zulassung einer Zubereitung aus Clostridium butyricum (FERM BP-2789) als Zusatzstoff in Futtermitteln für Junghennen (Zulassungsinhaber Miyarisan Pharmaceutical Co. Ltd., vertreten durch Miyarisan Pharmaceutical Europe S.L.U.)
Kommisjonens gjennomføringsforordning (EU) nr. 374/2013 av 23. april 2003 om godkjenning av et preparat av Clostridium butyricum (FERM BP-2789) som tilsetningsstoff i fôrvarer for livkyllinger (innehaver av godkjenningen: Miyarisan Pharmaceutical Co. Ltd, representert ved Miyarisan Pharmaceutical Europe S.L.U.)
History
15.02.2014
Adopted JCD confirmed entry into force date
15.02.2014
Compliance date in the EEA
14.02.2014
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
18.11.2013
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
23.04.2013
Adoption date in the EU
15.05.2013
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.